Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes

Author： Ramachandran Surya   Kartha C.C.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.90, Iss.8, 2012-08, pp. : 1005-1015

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Propionyl-Carnitine in Patients with Type 2 Diabetes and Peripheral Vascular Disease: Results of a Pilot Trial

By Ragozzino G.   Mattera E.   Madrid E.   Salomone P.   Fasano C.   Gioia F.   Acerra G.   Raffaele del Guercio   Federico P.  

Drugs in R&D, Vol. 5, Iss. 4, 2004-01 ,pp. : 185-190

Adis International

Access to resources Recommend Favorite

The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease

By Gatenby Victoria K   Kearney Mark T  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1333-1342

Informa Healthcare

Access to resources Recommend Favorite

Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3644-3655

Bentham Science Publishers

Access to resources Recommend Favorite

The Economics of Screening and Treatment in Type 2 Diabetes Mellitus

By Raikou M.   McGuire A.  

PharmacoEconomics, Vol. 21, Iss. 8, 2003-01 ,pp. : 543-564

Adis International

Access to resources Recommend Favorite

Screening for type 2 diabetes cost effective

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 601, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite